Ikapharmindo Putramas Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 900 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 3.94M 24h volume). The key difference: Ikapharmindo Putramas Tbk. and Kian Santang Muliatama Tbk. are close in size by market cap, and Kian Santang Muliatama Tbk. is more actively traded (3.94M versus 900). Which is the better fit depends on your goals.
| IKPM | RGAS | |
|---|---|---|
Market Cap | 308.29B | 312.28B |
Volume | 900 | 3.94M |
Lot | 9 | 39.45K |
Turnover | 164.2K | 834.26M |
Average Price | 182.44 | 211.49 |
Value | 164.2K | 834.26M |
Indicative Equilibrium Price | 183 | 214 |
Indicative Equilibrium Volume | 100 | 179.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →